J&J Says Cancer Drug Study Sinks Bayer's False Ad Claims
By Gianna Ferrarin · July 29, 2026, 4:40 PM EDT
Johnson & Johnson told a New York federal court that a peer-reviewed scientific journal's publication of a study on the active ingredient in its prostate cancer drug must end Bayer's claims...
To view the full article, register now.